Urban–Schosser–Spohn syndrome
Urban–Schosser–Spohn syndrome is a rare genetic disorder characterized by a combination of physical and developmental abnormalities. The syndrome was first described by the physicians Urban, Schosser, and Spohn in the late 20th century.
Symptoms and Signs[edit | edit source]
The symptoms of Urban–Schosser–Spohn syndrome vary widely among affected individuals. Common features include intellectual disability, seizures, microcephaly (small head size), hypotonia (low muscle tone), and distinctive facial features such as a prominent forehead, wide-set eyes, and a thin upper lip. Some individuals may also have congenital heart defects, hearing loss, and abnormalities of the skeletal system.
Causes[edit | edit source]
Urban–Schosser–Spohn syndrome is caused by mutations in a specific gene. The exact gene involved is currently unknown, but it is believed to play a crucial role in early brain development. The syndrome is inherited in an autosomal recessive manner, which means both copies of the gene in each cell must have mutations for an individual to be affected.
Diagnosis[edit | edit source]
Diagnosis of Urban–Schosser–Spohn syndrome is based on clinical examination and the presence of characteristic symptoms. Genetic testing may be used to confirm the diagnosis and identify the specific gene mutation.
Treatment[edit | edit source]
There is currently no cure for Urban–Schosser–Spohn syndrome. Treatment is symptomatic and supportive, and may include physical therapy, occupational therapy, and speech therapy to help improve motor skills and communication abilities. Medication may be used to manage seizures.
Prognosis[edit | edit source]
The prognosis for individuals with Urban–Schosser–Spohn syndrome varies depending on the severity of symptoms. With appropriate support and treatment, many individuals can lead fulfilling lives.
See Also[edit | edit source]
NIH genetic and rare disease info[edit source]
Urban–Schosser–Spohn syndrome is a rare disease.
| Urban–Schosser–Spohn syndrome Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
